The NOPHICO holding has an extraordinarily long history in the field of chemically produced medicines, having been in the Iranian pharma industry for more than 60 years. This has brought for NOPHICO a reputation as one of the most experienced and reliable private pharmaceutical holding in Iran. NOPHICO has now decided to enter the biotechnology field. NikouGen has been founded as a biotech division of NOPHICO Holding.
Following the success of recombinant proteins, therapeutic monoclonal antibodies (mAbs) represent the second wave of innovation created by the biotechnology industry during the past twenty years. It has been estimated ∼70 monoclonal antibody products will be on the market by 2020, and combined world-wide sales will be nearly $125 billion.
Our management team have highest university degrees in biotechnology, engineering, pharmacy, finance or business administration from the best German and Iranian universities and more than 20 years work experience in both countries. Due several years work experience in top European or American companies our managers are fully familiar with the working culture, necessary discipline and the needs of international companies
The treatment of millions of seriously ill patients is highly dependent on the safe and reliable production of biopharmaceuticals. Significant skill, experience, vigilance and commitment are critical to ensure the quality of biopharmaceuticals each time a new batch is made. At Nikougen, we have commitment to robust the quality of our biopharmaceuticals by using reliable partners and stringent quality control.
WHAT WE DO
NOPHICO has a presence in Iran for approximately 60 years and have reached millions of people in the fight against illnesses by using chemically produced medicines. Currently, Nikougen focuses on the biopharmaceuticals which are typically produced by Genetics Engineering methods. Five therapeutic areas have been targeted by Nikougen: oncology/hematology, rheumatology disorders, inflammation, nephrology and neuroscience.
We actively support and participate in international networks, which we believe are the pillars of cooperation and exchange in a highly globalized world.